About Us
Biomarker Technologies (BMK)
Biomarker Technologies(BMKGENE), as one of the leading provider of genomics services, is founded in 2009, headquartered in Beijing, China. BMKGENE has been actively engaged in innovation and development of high-throughput sequencing technologies and bioinformatics for over 14 years. Its business consists of science and technology services and BioCloud bioinformatics platform. BMKGENE has established long-term cooperation with various organizations, including universities, hospitals, research institutes, independent laboratories, pharmaceutical companies, plant breeding companies, medical and health institutes, etc., sitting in over 50 regions all over the world.
To innovate biotechnology
To Serve the society
To Benefit people
To create innovative biotechnology center and establish a symbolic enterprise in bio-industry
Our Advantages
Biomarker Technologies owns a passionate and highly-skilled R&D team of over 500 members composed of highly-educated technical staff, senior engineers, bioinformaticians and experts in diverse areas including biotechnology, agriculture, medicine, computing, etc. Our outstanding technical team has robust ability in tackling scientific and technical issues and has accumulated massive experience in diverse research area and contributed in hundreds of high-impact publications in Nature, Nature Genetics, Nature Communications, Plant Cell, etc. It owns over 60 nation patents of inventions and 200 software copyrights.
Main Business
Science and Technology Services
Providing over 60 comprehensive high-throughput biological measurements and bioinformatics services, covering genomics, transcriptomics, epigenetics, single-cell omics, proteomics, metabolomics, etc.
On-line Bioinformatics Platform
Providing efficient, safe and ease-to-use online bioinformatics analysis platform containing innovative customized analyzing tools, databases at PB-level, chatting section, training materials, etc.
Our Platforms
Leading, Multi-level High-throughput Sequencing Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5 MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Professional, Automatic Molecular Laboratory
Over 20,000 square feet place
Advanced biomolecular laboratory instruments
Standard labs of sample extraction, library construction, clean rooms, sequencing labs
Standard procedures from sample extraction to sequencing under strict SOPs
Multiple and flexible experimental designs fulfilling diverse research goals
Reliable, Ease-to-use On-line Bioinformatic Analysis Platform
Self-developed BMKCloud platform
CPUs with 41,104 memory and 3 PB total storage
4,260 computing cores with peak computing power over 121,708.8 Gflop per second.
Contact Us
Biomarker Technologies owns the most cutting-edge high-throughput sequencing platforms and high-performance computing platforms, serving for next-generation sequencing, third-generation sequencing, single-cell multiomics, proteomics, metabolomics and high-throughput data handling. Biomarker Technologies is committed to continuously creat greater value for its customers and lead the industrial transformation with high-quality innovations to realize its ultimate mission of benefiting humanity with genetic technology.
get a quote
Write your message here and send it to us